Ex Vivo Drug Sensitivity Testing to Predict Response to Venetoclax plus Azacitidine in Acute Myeloid Leukemia: Interim Results of the Prospective Multicenter Phase II Venex Trial

Heikki Kuusanmaki; Sari Kytola; Ida Vanttinen; Amanda Ranta; Tanja Ruokoranta; Annasofia Holopainen; Sirpa Koskela; Milla E. L. Kuusisto; Kimmo Porkka; Riikka Räty; Imre Vastrik; Krister Wennerberg; Caroline A. Heckman; Pia Ettala; Marja Pyorala; Johanna Rimpilainen; Timo Siitonen; Mika Kontro

doi:10.1182/blood-2021-147691

Ex Vivo Drug Sensitivity Testing to Predict Response to Venetoclax plus Azacitidine in Acute Myeloid Leukemia: Interim Results of the Prospective Multicenter Phase II Venex Trial

Heikki Kuusanmaki, Sari Kytola, Ida Vanttinen, Amanda Ranta, Tanja Ruokoranta, Annasofia Holopainen, Sirpa Koskela, Milla E. L. Kuusisto, Kimmo Porkka, Riikka Räty, Imre Vastrik, Krister Wennerberg, Caroline A. Heckman, Pia Ettala, Marja Pyorala, Johanna Rimpilainen, Timo Siitonen, Mika Kontro

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	Meeting Abstract 228
Journal	Blood
Volume	138
Number of pages	4
ISSN	0006-4971
DOIs	https://doi.org/10.1182/blood-2021-147691
Publication status	Published - 23 Nov 2021
MoE publication type	Not Eligible

Fields of Science

3122 Cancers

Access to Document

10.1182/blood-2021-147691

Cite this

Kuusanmaki, H., Kytola, S., Vanttinen, I., Ranta, A., Ruokoranta, T., Holopainen, A., Koskela, S., Kuusisto, M. E. L., Porkka, K., Räty, R., Vastrik, I., Wennerberg, K., Heckman, C. A., Ettala, P., Pyorala, M., Rimpilainen, J., Siitonen, T., & Kontro, M. (2021). Ex Vivo Drug Sensitivity Testing to Predict Response to Venetoclax plus Azacitidine in Acute Myeloid Leukemia: Interim Results of the Prospective Multicenter Phase II Venex Trial. Blood, 138, Article Meeting Abstract 228. https://doi.org/10.1182/blood-2021-147691

@article{76834caeb1ba40faa08dfb2e52be3149,

title = "Ex Vivo Drug Sensitivity Testing to Predict Response to Venetoclax plus Azacitidine in Acute Myeloid Leukemia: Interim Results of the Prospective Multicenter Phase II Venex Trial",

keywords = "3122 Cancers",

author = "Heikki Kuusanmaki and Sari Kytola and Ida Vanttinen and Amanda Ranta and Tanja Ruokoranta and Annasofia Holopainen and Sirpa Koskela and Kuusisto, {Milla E. L.} and Kimmo Porkka and Riikka R{\"a}ty and Imre Vastrik and Krister Wennerberg and Heckman, {Caroline A.} and Pia Ettala and Marja Pyorala and Johanna Rimpilainen and Timo Siitonen and Mika Kontro",

year = "2021",

month = nov,

day = "23",

doi = "10.1182/blood-2021-147691",

language = "English",

volume = "138",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

}

Kuusanmaki, H, Kytola, S, Vanttinen, I, Ranta, A, Ruokoranta, T, Holopainen, A, Koskela, S, Kuusisto, MEL, Porkka, K , Räty, R, Vastrik, I, Wennerberg, K, Heckman, CA, Ettala, P, Pyorala, M, Rimpilainen, J, Siitonen, T & Kontro, M 2021, 'Ex Vivo Drug Sensitivity Testing to Predict Response to Venetoclax plus Azacitidine in Acute Myeloid Leukemia: Interim Results of the Prospective Multicenter Phase II Venex Trial', Blood, vol. 138, Meeting Abstract 228. https://doi.org/10.1182/blood-2021-147691

TY - JOUR

T1 - Ex Vivo Drug Sensitivity Testing to Predict Response to Venetoclax plus Azacitidine in Acute Myeloid Leukemia

T2 - Interim Results of the Prospective Multicenter Phase II Venex Trial

AU - Kuusanmaki, Heikki

AU - Kytola, Sari

AU - Vanttinen, Ida

AU - Ranta, Amanda

AU - Ruokoranta, Tanja

AU - Holopainen, Annasofia

AU - Koskela, Sirpa

AU - Kuusisto, Milla E. L.

AU - Porkka, Kimmo

AU - Räty, Riikka

AU - Vastrik, Imre

AU - Wennerberg, Krister

AU - Heckman, Caroline A.

AU - Ettala, Pia

AU - Pyorala, Marja

AU - Rimpilainen, Johanna

AU - Siitonen, Timo

AU - Kontro, Mika

PY - 2021/11/23

Y1 - 2021/11/23

KW - 3122 Cancers

U2 - 10.1182/blood-2021-147691

DO - 10.1182/blood-2021-147691

M3 - Meeting Abstract

SN - 0006-4971

VL - 138

JO - Blood

JF - Blood

M1 - Meeting Abstract 228

ER -